{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:54:21Z","timestamp":1790830461154,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T00:00:00Z","timestamp":1466467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31370194"],"award-info":[{"award-number":["31370194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31570163"],"award-info":[{"award-number":["31570163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Projects of Guangzhou","award":["201504010032"],"award-info":[{"award-number":["201504010032"]}]},{"name":"Dongguan City Key Program of Science and Technology","award":["2014108101014"],"award-info":[{"award-number":["2014108101014"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0156984","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T16:01:21Z","timestamp":1466611281000},"page":"e0156984","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon"],"prefix":"10.1371","volume":"11","author":[{"given":"Xiaobo","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14712598.2015.993374","article-title":"Adenoviruses as gene\/vaccine delivery vectors: promises and pitfalls","volume":"15","author":"MB Appaiahgari","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"N Tatsis","year":"2004","journal-title":"Mol Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/erv.13.15","article-title":"Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials","volume":"12","author":"S Capone","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2005.08.101","article-title":"Development of nonhuman adenoviruses as vaccine vectors","volume":"24","author":"DS Bangari","year":"2006","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/02648725.2006.10648067","article-title":"Development of group B adenoviruses as gene transfer vectors","volume":"22","author":"D Stone","year":"2006","journal-title":"Biotechnol Genet Eng Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/156652307781369137","article-title":"Adenovirus vectors composed of subgroup B adenoviruses","volume":"7","author":"F Sakurai","year":"2007","journal-title":"Curr Gene Ther"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.vaccine.2008.12.039","article-title":"Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector","volume":"27","author":"Q Zhang","year":"2009","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virol.2005.08.024","article-title":"The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3","volume":"343","author":"D Sirena","year":"2005","journal-title":"Virology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/cgt.2010.79","article-title":"Oncolytic adenovirus based on serotype 3","volume":"18","author":"O Hemminki","year":"2011","journal-title":"Cancer Gene Ther"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1128\/JVI.79.8.5090-5104.2005","article-title":"Development and assessment of human adenovirus type 11 as a gene transfer vector","volume":"79","author":"D Stone","year":"2005","journal-title":"J Virol"},{"issue":"15","key":"ref11","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity","volume":"77","author":"R Vogels","year":"2003","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.gt.3302097","article-title":"Human adenovirus type 35: nucleotide sequence and vector development","volume":"10","author":"W Gao","year":"2003","journal-title":"Gene Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.gt.3301903","article-title":"Development of an Ad7 cosmid system and generation of an Ad7 E1E3HIVMN env\/rev recombinant virus","volume":"10","author":"X Nan","year":"2003","journal-title":"Gene Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"JM Bergelson","year":"1997","journal-title":"Science"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1128\/JVI.72.10.7909-7915.1998","article-title":"The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F","volume":"72","author":"PW Roelvink","year":"1998","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"12109","DOI":"10.1128\/JVI.01370-06","article-title":"A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells","volume":"80","author":"S Tuve","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"H Wang","year":"2011","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.138.1.193","article-title":"Direct Ca2-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion","volume":"138","author":"NA Chitaev","year":"1997","journal-title":"J. Cell Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/excr.1994.1103","article-title":"Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins","volume":"211","author":"S Schafer","year":"1994","journal-title":"Exp. Cell Res"},{"issue":"21","key":"ref20","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1128\/JVI.01825-13","article-title":"Structural and functional studies on the interaction of adenovirus fiber knobs and desmoglein 2","volume":"87","author":"H Wang","year":"2013","journal-title":"J Virol"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1128\/JVI.00205-12","article-title":"A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses","volume":"86","author":"H Wang","year":"2012","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcb.22328","article-title":"The influence of innate and pre-existing immunity on adenovirus therapy","volume":"108","author":"AK Zaiss","year":"2009","journal-title":"J Cell Biochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e33428","DOI":"10.1371\/journal.pone.0033428","article-title":"Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine","volume":"7","author":"A Pandey","year":"2012","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CDLI.11.2.351-357.2004","article-title":"Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States","volume":"11","author":"E Nwanegbo","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1\u20132","key":"ref26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.virusres.2011.06.017","article-title":"Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon","volume":"160","author":"X Tian","year":"2011","journal-title":"Virus Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.virol.2012.12.014","article-title":"Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera","volume":"437","author":"B Yu","year":"2013","journal-title":"Virology"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"SM Sumida","year":"2005","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/JVI.06254-11","article-title":"Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection","volume":"86","author":"RR Bradley","year":"2012","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/JVI.70.3.1836-1844.1996","article-title":"Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues","volume":"70","author":"L Crawford-Miksza","year":"1996","journal-title":"J Virol"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.06165-11","article-title":"Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions","volume":"86","author":"RR Bradley","year":"2012","journal-title":"J Virol"},{"issue":"37","key":"ref32","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1016\/j.vaccine.2009.06.041","article-title":"Molecular modeling and epitopes mapping of human adenovirus type 3 hexon protein","volume":"27","author":"X Yuan","year":"2009","journal-title":"Vaccine"},{"issue":"15","key":"ref33","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1128\/JVI.07076-11","article-title":"Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdv-3) and HAdV-7 reside in multiple hexon hypervariable regions","volume":"86","author":"H Qiu","year":"2012","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"DM Roberts","year":"2006","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e33920","DOI":"10.1371\/journal.pone.0033920","article-title":"Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses","volume":"7","author":"JT Bruder","year":"2012","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jgm.1332","article-title":"Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5","volume":"11","author":"S Abe","year":"2009","journal-title":"J Gene Med"},{"issue":"24","key":"ref37","doi-asserted-by":"crossref","first-page":"12775","DOI":"10.1128\/JVI.76.24.12775-12782.2002","article-title":"Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon","volume":"76","author":"H Wu","year":"2002","journal-title":"J Virol"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1128\/JVI.00814-12","article-title":"Genome sequence of the first human adenovirus type 14 isolated in China","volume":"86","author":"Q Zhang","year":"2012","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00705-012-1364-1","article-title":"Characterization of malleability and immunological properties of human adenovirus type 3 hexon hypervariable region 1","volume":"157","author":"T Zhong","year":"2012","journal-title":"Arch Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1128\/JVI.72.12.10260-10264.1998","article-title":"Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype","volume":"72","author":"JG Gall","year":"1998","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/10430340252769824","article-title":"Hexon gene switch strategy for the generation of chimeric recombinant adenovirus","volume":"13","author":"R Youil","year":"2002","journal-title":"Hum Gene Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0156984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T14:45:37Z","timestamp":1600785937000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0156984"}},"subtitle":[],"editor":[{"given":"Ilya","family":"Ulasov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,21]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0156984","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,21]]}}}